Rense Buijvoets/LinkedIn
May 26, 2026, 14:23
Rense Buijvoets: What If Clots Could Be Treated Exactly Where They Form?
Rense Buijvoets, Co-owner and Managing director at Sensu, shared a post on LinkedIn:
”1 in 4 deaths worldwide are caused by thrombosis.
What if blood clots could be targeted directly at their source?
TGD001, TargED’s fusion protein in development, binds to blood clots so it can act where it is needed most. By activating plasmin locally, it helps break down VWF and fibrin, allowing the clot to dissolve and blood flow to return.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Aug 31, 2026, 05:35Does LDL Cholesterol Influence VTE Risk? – Ordo Fraterna Fibonacci
-
Aug 31, 2026, 05:19Tania Ahuja: Apixaban in Abdominal Transplant Patients
-
Aug 31, 2026, 04:28Reza Hafidz Irawan։ Automated Antibody Titration With Erytra Eflexis
-
Aug 31, 2026, 04:17Safa Chenganath: Stenosis vs Thrombosis – Hemodialysis Vascular Access
-
Aug 30, 2026, 17:13J. Meireles-Brandao: Hypertension, Inflammation and Lipoprotein Disease
-
Aug 30, 2026, 17:10Hugh Nguyen: Leading the New Era of Blood Services Across Asia Pacific
-
Aug 30, 2026, 17:09Transforming Childhood Through Access to Hemophilia Treatment – World Federation of Hemophilia
-
Aug 30, 2026, 17:07Raj Bharath: Connecting Clinicians and Researchers to Advance Transfusion Medicine
-
Aug 30, 2026, 17:04Rana Al Hrout: Free FRCPath Haematology Part 1 Exam Preparation Session